Table 3.
IOP and C/D ratios in each study group.
Preservative-free treatment (tafluprost) (n=30) | BAK-containing treatment (latanoprost) (n=30) | Untreated (control) (n=30) | Total (n=90) | |
---|---|---|---|---|
IOP (mmHg) mean ± SD | ||||
C/D ratio | 12.00∗∗‡ ± 1.53 | 12.40 ± 1.50 | 13.60∗∗‡ ± 2.88 | 12.67 ± 2.16 |
Mean ± SD | 0.74∗∗∗‡ ± 0.10 | 0.69∗∗∗‡ ± 0.10 | 0.50∗∗∗‡ ± 0.16 | 0.64 ± 0.16 |
SD, standard deviation. ∗∗p < 0.01; ∗∗∗p < 0.001; ‡significant difference relative to control group.